Division of Cardiovascular Medicine, Brigham and Women's Hospital (M.P.).
Department of Cardiology, Cedars-Sinai Medical Center (S.C.).
Circ Res. 2022 Feb 18;130(4):496-511. doi: 10.1161/CIRCRESAHA.121.320702. Epub 2022 Feb 17.
Peripheral artery disease (PAD) is a prevalent condition that confers substantial morbidity and mortality and remains underdiagnosed as well as undertreated in the overall population. Although PAD prevalence is similar or higher in women compared with men, associations of traditional and nontraditional risk factors with PAD and clinical manifestations of PAD differ by sex and may contribute to delayed or lack of diagnosis in women. Such sex-based differences in the manifestation of PAD may arise from sexual dimorphism in the vascular substrate in health as well as sex variation in the responses to vascular stressors. Despite the availability of proven therapies for improving symptoms and reducing risk of ischemic cardiovascular and limb events among patients with diagnosed PAD, important sex differences in treatment and outcomes have been observed. We provide an overview of current knowledge regarding sex differences in the epidemiology, pathophysiology, clinical presentation, and management of PAD.
外周动脉疾病(PAD)是一种普遍存在的疾病,会导致大量的发病率和死亡率,并且在整个人群中都存在诊断不足和治疗不足的情况。尽管与男性相比,女性的 PAD 患病率相似或更高,但传统和非传统危险因素与 PAD 以及 PAD 的临床表现之间的关联因性别而异,这可能导致女性的诊断延迟或缺乏。PAD 表现出的这种基于性别的差异可能源于健康的血管基质中的性别二态性,以及对血管应激源的反应中的性别差异。尽管已经有了经过验证的治疗方法,可以改善患有确诊 PAD 患者的症状并降低缺血性心血管和肢体事件的风险,但在治疗和结局方面仍存在重要的性别差异。我们概述了目前关于 PAD 的流行病学、病理生理学、临床表现和管理方面的性别差异的相关知识。